# FDA Inspection 1265626 - RSH Medical LLC - March 27, 2025

Source: https://www.keypedia.com/records/fda_inspections/rsh-medical-llc/f218ed63-c090-415a-b2a5-4a66cfef02c9
Source feed: FDA_Inspections

> FDA Inspection 1265626 for RSH Medical LLC on March 27, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265626
- Company Name: RSH Medical LLC
- Inspection Date: 2025-03-27
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1265626 - 2025-03-27](https://www.keypedia.com/records/fda_inspections/rsh-medical-llc/61f8e83c-e1a1-463d-801a-1191e6528610)
- [FDA Inspection 663995 - 2010-05-19](https://www.keypedia.com/records/fda_inspections/rsh-medical-llc/94db71d8-e7bd-4647-a955-163254ae4079)

Company: https://www.keypedia.com/companies/rsh-medical-llc/61684acf-994d-4b97-8b03-6f86a3f918ac

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d